Search

Your search keyword '"Mapara A"' showing total 1,644 results

Search Constraints

Start Over You searched for: Author "Mapara A" Remove constraint Author: "Mapara A"
1,644 results on '"Mapara A"'

Search Results

1. Hot Carrier Dynamics in Operational Metal Halide Perovskite Solar Cells

3. Naming the colonized and vanquished: archiving the successes of the imperial enterprise

4. Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma

6. The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease

9. Corrigendum

10. The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses

11. The relationship between climate change induced natural disasters and selected nutrition outcomes: a case of cyclone Idai, Zimbabwe

14. Region-Based Multiple Object Tracking with LSTM Supported Trajectories

15. S264: EDIT-301 SHOWS PROMISING PRELIMINARY SAFETY AND EFFICACY RESULTS IN THE PHASE I/II CLINICAL TRIAL (RUBY) OF PATIENTS WITH SEVERE SICKLE CELL DISEASE USING HIGHLY SPECIFIC AND EFFICIENT ASCAS12A ENZYME

16. S270: TRANSFUSION INDEPENDENCE AFTER EXAGAMGLOGENE AUTOTEMCEL IN PATIENTS WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA

18. Coherent two-dimensional Fourier transform spectroscopy using a 25 Tesla resistive magnet.

19. Impact of climate change-induced natural disasters on intangible cultural heritage related to food: a review

21. Amplification of Signal on Cell Surfaces in Molecular Cascades

22. Log-structured Protocols in Delos.

24. Hybrid repair of type II thoracoabdominal aortic aneurysm using modified branch-first technique

25. IFN-γR/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease

27. Lovotibeglogene Autotemcel Gene Therapy for Sickle Cell Disease: 60 Months Follow-up

29. Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia

30. Exagamglogene Autotemcel for Severe Sickle Cell Disease

38. IFN-[gamma]R/STAT1 signaling in recipient hematopoietic antigen-presenting cells suppresses graft-versus-host disease

39. Drug use pattern for emergency psychiatric conditions in a tertiary care hospital: A prospective observational study

44. Efficacy and Safety in Patients (Pts) with Sickle Cell Disease (SCD) Who Have Received Lovotibeglogene Autotemcel (Lovo-cel) Gene Therapy: Up to 60 Months of Follow-up

45. AsCas12a Gene Editing of HBG1/2 Promoters with Edit-301 Results in Early and Sustained Normalization of Hemoglobin and Increased Fetal Hemoglobin in Patients with Severe Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia

46. RGI-2001 with CNI-Based Prophylaxis Demonstrates Better Acute Gvhd-Free Survival Following Myeloablative Allohct without Increased Relapse: Comparison of a Multi-Center Phase 2b Study with a Contemporaneous CIBMTR Cohort

47. Elimination of Vaso-Occlusive Crises after Exagamglogene Autotemcel in Patients with Severe Sickle Cell Disease

48. Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Shows Rapid Primary Engraftment with CD33-Negative Hematopoiesis in Patients with High-Risk Acute Myeloid Leukemia (AML) and Avoids Hematopoietic Toxicity during Gemtuzumab Ozogamicin (GO) Maintenance Post-Hematopoietic Cell Transplant (HCT).

49. Transfusion Independence after Exagamglogene Autotemcel in Patients with Transfusion-Dependent β-Thalassemia

Catalog

Books, media, physical & digital resources